Autoantibodies to oxidized low density lipoprotein have been shown to be an independent predictor of the progression of carotid atherosclerosis. This study examines the relationship between low density lipoprotein fatty acid composition and autoantibodies to both malondialdehyde-modified and copper-
Role of oxidized low-density lipoprotein in the atherosclerosis of uremia
✍ Scribed by Drüeke, Tilman B.; Khoa, Thao Nguyen; Massy, Ziad A.; Witko-Sarsat, Véronique; Lacour, Bernard; Descamps-Latscha, Béatrice
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 964 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.
✦ Synopsis
Lipoprotein oxidation is involved in the genesis of atherosclerosis. In chronic renal failure (CRF), oxidative stress is enhanced because of an imbalance between pro-oxidant and antioxidant systems. Oxidative modifications of low-density lipoproteins (LDLs) occur not only at the level of lipid moiety, but also of protein moiety. We have shown that oxidation of LDL by hypochlorous acid (HOCl) in vitro, reflecting increased myeloperoxidase activity in vivo, leads to modifications of apoliproteins such that the latter in turn are capable of triggering macrophage nicotinamide adenine dinucleotide phosphate-oxidase activation. These oxidative changes of LDL protein moiety, if shown to occur to a significant extent in uremic patients in vivo, may represent an important alternative pathway in the pathogenesis of atheromatous lesions.
📜 SIMILAR VOLUMES
## Abstract ## Objective Findings of recent in vivo and in vitro studies suggest that oxidized low‐density lipoprotein (ox‐LDL) plays a role in the degeneration of cartilage. The purpose of this study was to determine whether ox‐LDL induces chondrocyte senescence through binding to lectin‐like ox‐
Low-density lipoprotein receptor (LDLR) is a major apolipoprotein E (APOE) receptor and thereby is critical to cholesterol homeostasis and, possibly, Alzheimer disease (AD) development. We previously identified a single nucleotide polymorphism (SNP), rs688:C>T, that modulates LDLR exon 12 splicing a
We conducted this study to investigate whether antioxidized low-density lipoprotein (a-oxLDL) is an antibody to cryptic and/or neo-antigen on p,-glycoprotein I (GPI), which is introduced by binding to anionic phospholipid, similar to that of GPI-dependent anticardiolipin antibody (aCL) employing a-o